These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37595751)

  • 1. Preparation, Characterization, in-vitro and in-vivo Pharmacokinetic Evaluation of Thermostable Dimethyl Fumarate Cocrystals.
    Alam Q; Ganeshpurkar A; Singh SK; Krishnamurthy S
    J Pharm Sci; 2024 Mar; 113(3):647-658. PubMed ID: 37595751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Gastroprotective and Thermostable Cocrystal of Dimethyl Fumarate: Its Preparation, Characterization, and
    Alam Q; Ganeshpurkar A; Singh SK; Krishnamurthy S
    ACS Omega; 2023 Jul; 8(29):26218-26230. PubMed ID: 37521634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S; Gupta A; Prasad R; Singh S
    Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin cocrystals: Characterization and evaluation.
    Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
    J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-Ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study.
    Zhou Z; Calatayud M; Contreras-García J; Li L; Tong HHY; Zheng Y
    J Pharm Sci; 2019 Oct; 108(10):3340-3347. PubMed ID: 31145922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
    Wu N; Zhang Y; Ren J; Zeng A; Liu J
    RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
    Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
    J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
    Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
    Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
    Zeng QZ; Ouyang J; Zhang S; Zhang L
    Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
    Chaudhari KR; Savjani JK; Savjani KT; Shah H
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of Carbamazepine Cocrystals: Characterization,
    Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
    Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
    Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
    Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.